Comparable stake leader
WOLVERINE ASSET MANAGEMENT LLC
SEC ownership of Translational Development Acquisition Corp.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001926599.
Disclosed value leader
WOLVERINE ASSET MANAGEMENT LLC
Comparable rows
27/50
Latest evidence
27 May 2026
- Public ticker
- TDAC, TDACU, TDACW on Nasdaq
- Parsed ownership sources
- 13D/G and 13F
- Largest SEC-reported holder
- WOLVERINE ASSET MANAGEMENT LLC
- Latest 13D/G holder
- WOLVERINE ASSET MANAGEMENT LLC
- Latest parsed ownership date
- 27 May 2026
- Issuer CIK
- 0001926599
- Issuer location
- New York, NY
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Translational Development Acquisition Corp. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WOLVERINE ASSET MANAGEMEN...
Disclosed value leader
WOLVERINE ASSET MANAGEMEN...
Comparable rows
27/50
Latest evidence
27 May 2026
13D/G
13F
Lead comparable stake: 9%
23 rows are not safely comparable across share classes.
13D/G row: WOLVERINE ASSET MANAGEMENT LLC
Showing 1-8 of 50 holder rows.
Quick read
WOLVERINE ASSET MANAGEMENT LLC leads the comparable SEC ownership view at 9%.
27 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WOLVERINE ASSET MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
WOLVERINE ASSET MANAGEMENT LLC
9%
Magnetar Financial LLC
7.5%
AQR CAPITAL MANAGEMENT LLC
6.4%
GOLDMAN SACHS GROUP INC
6.1%
Linden Capital L.P.
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC |
13D/G
13F
Company
|
9%
|
$16,069,623
1,557,134 shares
|
+$2,089,212 | 30 Sep 2025 |
| Magnetar Financial LLC |
13F
13D/G
Company
|
7.5%
from 13D/G
|
$13,824,070
1,950,000 shares
mixed-class rows
|
— | 31 Mar 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
|
6.4%
|
$11,087,889
1,099,989 shares
|
-$3,880,911 | 31 Mar 2025 |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
THE GOLDMAN SACHS GROUP, INC. · Company
|
6.1%
|
$11,205,296
1,054,120 shares
|
$0 | 31 Mar 2026 |
| Linden Capital L.P. |
13D/G
Linden Advisors LP
|
5.5%
|
$10,117,500
950,000 shares
|
$0 | 27 May 2026 |
| BANK OF MONTREAL /CAN/ |
13D/G
Bank of Montreal
|
4.6%
|
$8,240,000
800,000 shares
|
-$2,060,000 | 30 Jun 2025 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13D/G
13F
Company
|
2.3%
|
$4,032,000
400,000 shares
|
-$5,040,000 | 31 Mar 2025 |
| Karpus Management, Inc. |
13F
Company
|
3.5%
|
$6,372,168
603,425 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 06 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-7 of 7 reporting-owner rows connected to Translational Development Acquisition Corp.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
7
Largest Forms 3/4/5 holder
Christopher Kenneth Jarratt
Net 12M change
$0
Latest report
27 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Christopher Kenneth Jarratt | Director | Mixed | 20 Dec 2024 | |||
| Curtis T. Keith | Director | Mixed | 20 Dec 2024 | |||
| Avanindra C. Das | Chief Financial Officer | Mixed | 20 Dec 2024 | |||
| TDAC Partners LLC | 10%+ Owner | Mixed | 20 Dec 2024 | |||
| Michael B. Hoffman | Chairman and CEO, Director | Mixed | 27 May 2026 | |||
| Matthew A. Kestenbaum | Director | Mixed | 20 Dec 2024 | |||
| E. Premkumar Reddy | Director | Mixed | 20 Dec 2024 |
Recent insider transactions for Translational Development Acquisition Corp.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael B. Hoffman | TDAC | Warrants | Purchase | 53,395 | 53,395 | 27 May 2026 | Direct |
* marks a reported price that did not pass the local price check.